3 ms·
The article seems like a bunch of whining to be honest and an effort to call out winners based on best guesses of what's the best approach. The US is reserving
by refurb 6y ago
The article seems like a bunch of whining to be honest and an effort to call out winners based on best guesses of what's the best approach.
The US is reserving doses for a 2nd shot. Other countries are not, like the UK. The UK is allowing 2nd doses far later than was tested in trials. Is that the best approach? Maybe. But we don't know right now.
It's certainly trendy as hell to trash how the US is handling Covid - and don't get me wrong, there is certainly room for improvement. But there are plenty of countries who are dropping the ball and flying under the radar (as a Canadian - I'm looking at my own country and the numerous mistakes made so far; Covid has absolutely exploded in the past 2 months, turning us from a good example to a disaster).
And suffice to say it's American companies - Pfizer, Moderna, who led the way in get vaccines to market. Yes, BioNTech had critical technology, but they needed a major pharma company to bring it to the 10 yard line.